[ad_1]
The Belgian brain imaging company icometrix has announced that it has received a CPT III code from the American Medical Association allowing the reimbursement of its FDA cleared brain MRI quantification software.
Quantitative brain analysis software supported by icometrix AI provides measurements for brain MRI scans to help clinicians diagnose, monitor, and evaluate treatment responses in patients with neurological diseases, such as Alzheimer’s disease. Alzheimer’s disease and dementia, multiple sclerosis, epilepsy, stroke and Parkinson’s disease.
The CPT code will allow qualified healthcare professionals to report their use of the icometrix brain imaging AI software as a practice expense.
THE GREAT TREND
iconometer received $18 million in funding in 2019 to develop its brain software. The Belgian company obtained FDA clearance for its icobrain-ctp offering in February 2020.
Last month, the company announcement He got a grant from Michael J. Fox Foundation to search for brain MRI biomarkers of Parkinson’s disease in collaboration with a professor of neurology and neurological sciences at Stanford Medicine.
In March, iconometer received £1,417,658 ($1,798,944) grant from the National Institute for Health and Care Research to accelerate multiple sclerosis imaging research.
Another company using AI software to help providers diagnose brain disorders is a South Korean health tech company Neurophet. In April he obtained certification from the Health Sciences Authority of Singapore for its AI-enabled Degenerative Brain Disease Diagnosis Support Software.
[ad_2]
Source link
